Home NDC 60505-6152-01 NDC 60505-6152-01 - Ceftriaxone Sodium This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 60505-6152
Requested NDC 60505-6152-01
Package NDCs from labels 60505-6152-4, 60505-6152-1, 60505-6152-01
Manufacturer Sportpharm LLC | ASCLEMED USA INC. DBA ENOVACHEM
Effective date 2026-04-24
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 60505-6152-1 Ceftriaxone Sodium 1 in 1 VIAL, SINGLE-USE INJECTION, POWDER, FOR SOLUTION 1 11 60505-6152-1 Ceftriaxone Sodium 10 in 1 CARTON INJECTION, POWDER, FOR SOLUTION 10 11 60505-6152-4 Ceftriaxone Sodium 1 in 1 CARTON INJECTION, POWDER, FOR SOLUTION 1 11 60505-6152-4 Ceftriaxone Sodium 1 in 1 VIAL, SINGLE-USE INJECTION, POWDER, FOR SOLUTION 1 11
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 60505-6152 CEFTRIAXONE SODIUM INJECTION, POWDER, FOR SOLUTION [APOTEX CORP.] 11 Current NDC, Legacy NDC, 4 package rows 20230831_5116231f-82d1-44be-b08e-560c9a50e5c5.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 2 of 2 · 36 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Ceftriaxone Sodium CEFTRIAXONE SODIUM Proficient Rx LP 790279d4-2456-4091-abec-960b78885432 2024-02-01 Warnings, Adverse reactions Exact identifier application number: ANDA203702 ndc (package): 82804-066-10 ndc (package): 82804-066-01 ndc (product): 82804-066 rxcui: 1665005 spl id: 790279d4-2456-4091-abec-960b78885432 spl set id: 790279d4-2456-4091-abec-960b78885432 unii: 023Z5BR09K Ceftriaxone Sodium CEFTRIAXONE SODIUM A-S Medication Solutions 1aa0a4ee-1b39-4c3d-a7a3-33dded6fe28c 2024-01-31 Warnings, Adverse reactions Exact identifier rxcui: 309092 unii: 023Z5BR09K Ceftriaxone Sodium CEFTRIAXONE SODIUM A-S Medication Solutions ff8e830a-c288-46fb-9e19-ec2017943c07 2024-01-31 Warnings, Adverse reactions Exact identifier rxcui: 309092 unii: 023Z5BR09K ceftriaxone CEFTRIAXONE Sagent Pharmaceuticals 5cf93bc5-9e4c-4734-bc02-c7d0ac071022 2023-11-08 Warnings, Adverse reactions Exact identifier rxcui: 1665046 rxcui: 1665005 rxcui: 1665021 unii: 023Z5BR09K Ceftriaxone CEFTRIAXONE Fresenius Kabi USA, LLC 7ea1db43-40fa-417b-8911-ae98092070a0 2023-09-30 Warnings, Adverse reactions Exact identifier rxcui: 1665046 rxcui: 1665005 rxcui: 1665021 unii: 023Z5BR09K Ceftriaxone Sodium CEFTRIAXONE SODIUM Asclemed USA, Inc. f01cf0e5-caaf-4759-ba21-50f3aceff523 2023-09-02 Warnings, Adverse reactions Exact identifier application number: ANDA203702 ndc (package): 76420-596-10 ndc (package): 76420-596-01 ndc (product): 76420-596 rxcui: 1665005 spl id: 045b6441-f12b-f2b4-e063-6394a90ad0ac spl set id: f01cf0e5-caaf-4759-ba21-50f3aceff523 unii: 023Z5BR09K Ceftriaxone Sodium CEFTRIAXONE SODIUM Apotex Corp. 5116231f-82d1-44be-b08e-560c9a50e5c5 2023-08-31 Warnings, Adverse reactions Exact identifier application number: ANDA203702 ndc (package): 60505-6149-4 ndc (package): 60505-6149-0 ndc (package): 60505-6151-1 ndc (package): 60505-6148-4 ndc (package): 60505-6151-4 ndc (package): 60505-6152-1 ndc (package): 60505-6148-0 ndc (package): 60505-6152-4 ndc (product): 60505-6148 ndc (product): 60505-6151 ndc (product): 60505-6149 ndc (product): 60505-6152 ndc11 (package): 60505615201 rxcui: 1665046 rxcui: 1665005 rxcui: 309092 rxcui: 1665021 spl id: 0432e6c3-ad77-726c-e063-6294a90a798c spl set id: 5116231f-82d1-44be-b08e-560c9a50e5c5 unii: 023Z5BR09K Ceftriaxone Sodium CEFTRIAXONE SODIUM Apotex Corp. ac03a72c-0e35-40f9-b7fc-081badb5f19c 2023-01-28 Warnings, Adverse reactions Exact identifier unii: 023Z5BR09K Ceftriaxone CEFTRIAXONE SODIUM Samson Medical Technologies, LLC 5cd2d96f-83e5-4326-ae87-d0ede4ba493a 2023-01-15 Warnings, Adverse reactions Exact identifier unii: 023Z5BR09K Ceftriaxone CEFTRIAXONE Proficient Rx LP fcf401df-bcdc-4773-a63b-9741c0f74b3d 2022-11-01 Warnings, Adverse reactions Exact identifier rxcui: 1665046 unii: 023Z5BR09K Ceftriaxone Sodium CEFTRIAXONE SODIUM Proficient Rx LP a25ab5ea-c46d-4562-8f7e-0ccffc2ab069 2022-10-01 Warnings, Adverse reactions Exact identifier rxcui: 1665046 unii: 023Z5BR09K Ceftriaxone Sodium CEFTRIAXONE SODIUM Proficient Rx LP 42ba7a9d-7d2b-4eac-af59-897151a8c924 2022-05-02 Warnings, Adverse reactions Exact identifier application number: ANDA203702 rxcui: 1665021 unii: 023Z5BR09K Ceftriaxone Sodium CEFTRIAXONE SODIUM Hospira, Inc 9d1f630b-e759-4395-9d01-ddc90e4fea75 2022-03-09 Warnings, Adverse reactions Exact identifier rxcui: 1665046 rxcui: 1665021 unii: 023Z5BR09K CEFTRIAXONE AND DEXTROSE CEFTRIAXONE B. Braun Medical Inc. 67153914-16bc-490d-82d7-638061618467 2022-01-13 Warnings, Adverse reactions Exact identifier rxcui: 1665046 rxcui: 1665021 unii: 023Z5BR09K 9ec4aee1-f85a-4b99-8ed4-f48a3023b304 cd8c0719-fa52-430d-a9f4-7b326de7a0ae 2020-05-29 Warnings, Adverse reactions Exact identifier spl id: 9ec4aee1-f85a-4b99-8ed4-f48a3023b304 spl set id: cd8c0719-fa52-430d-a9f4-7b326de7a0ae Ceftriaxone CEFTRIAXONE Hikma Pharmaceuticals USA Inc. 1f8776bd-4f5b-427a-849a-6b8338f7997d 2019-04-24 Warnings, Adverse reactions Exact identifier unii: 023Z5BR09K
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.